Liver Cancer
Copyright ©The Author(s) 2005.
World J Gastroenterol. Sep 14, 2005; 11(34): 5266-5272
Published online Sep 14, 2005. doi: 10.3748/wjg.v11.i34.5266
Figure 1
Figure 1 Northern blot validation of FGFR3 expression in matched HCC/non-neoplastic liver tissue and cell lines.
Figure 2
Figure 2 Standard curve and amplification plots of FGFR3 and GAPDH by quantitative real-time PCR. Starting quantity FGFR3 (A) and GAPDH (B); cycle FGFR3 (C) and GAPDH (D).
Figure 3
Figure 3 IHC of FGFR3 in HCC and matched non-neoplastic liver tissues. A, B: H and E; C, D: FGFR3.
Figure 4
Figure 4 Association between FGFR3 staining, HCC differentiation and nuclear grade. A: H and E; B: FGFR3.